Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Clinical trial NCT02966587 · WITHDRAWN
Trial details
- NCT number
- NCT02966587
- Sponsor
- University of Washington
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2023-05-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.